Novel antileukemic sterol glycosides from Ajuga salicifolia

Akbay, Pinar and Gertsch, Juerg and Cahs, Ihsan and Heilmann, Jörg and Zerbe, Oliver and Sticher, Otto (2002) Novel antileukemic sterol glycosides from Ajuga salicifolia. Helvetica chimica acta 85 (7), pp. 1930-1942.

Full text not available from this repository.

Abstract

Two novel and three new sterol glycosides were isolated from the MeOH ext. of the aerial parts of Ajuga salicifolia (L.) Schreber. The structures of the compds. were elucidated as (3R,16S,17S,20R,22S,23S,24S,25S)-16,23:16,27:22,25-triepoxy-3-(beta -D-glucopyranosyloxy)coprostigmast-7-en-17-ol (I), (3R,16S,17S,20R,22S,23S,24S,25S)-16,23:16,27:22,25-triepoxy-3-{[beta -D-glucopyranosyl-(1->2)-beta -D-glucopyranosyl]oxy}coprostigmast-7-en-17-ol (II), (3R,16S,17R,20S,22R,24S,25S)-22,25-epoxy-3,27-bis(beta -D-glucopyranosyloxy)coprostigmast-7-en-16-ol (III), (3R,16S,17R,20S,22R,24S,25S)-22,25-epoxy-3-{[beta -D-glucopyranosyl-(1->2)-beta -D- glucopyranosyl]oxy}-27-(beta -D-glucopyranosyloxy)coprostigmast-7-en-16-ol (IV), and (3R,16R,17S,20R,22S,23S,24S,25S)-22,25-epoxy-3-(beta -D-glucopyranosyloxy)coprostigmast-7-ene-16,17,23,27-tetrol 27-acetate (V) by means of 1D and 2D NMR spectroscopy and HR-MALDI mass spectrometry. The novel compds. which consist of three addnl. ring systems at the coprostigmastane skeleton, were named ajugasalicioside A (I) and B (II), and the new compds. C (III), D (IV) and E (V). In cytotoxicity assays (HeLa cells, Jurkat T cells, and peripheral mononuclear blood cells), ajugasaliciosides A-D specifically inhibited the viability and growth of Jurkat T-leukemia cells at concns. below 10 micro M. Ajugasalicioside A (I; IC50 = 6 micro m) and C (III: IC50 = 3 micro M) were the most active compds. I induced cell-cell contact, inhibited Jurkat T cell proliferation. and up-regulated mRNA levels of the cell-cycle regulator cyclin D1, which might be an indication for cell differentiation. Furthermore, I down-regulated the mRNA levels of the NF-kB subunit p65 in a concn.-dependent manner. These effects were not found for ajugasalicioside B (II), which has an addnl. glucose unit, and the onset of cytotoxicity of II (IC50 = 10 micro M) was delayed by 24 h.

Item Type:Article
Additional information (public):CAN 138:22094 11-1 Plant Biochemistry 478015-46-2P (Ajugasalicioside A); 478015-47-3P (Ajugasalicioside B); 478015-48-4P (Ajugasalicioside C); 478015-49-5P (Ajugasalicioside D); 478015-50-8P (Ajugasalicioside E) Role: NPO (Natural product occurrence), PAC (Pharmacological activity), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) (cytotoxicity, isolation, and structure of antileukemic sterol glycosides from Ajuga salicifolia)
Institutions: Chemistry and Pharmacy > Institute of Pharmacy > Pharmaceutical Biology (Prof. Heilmann)
Identification Number:
ValueType
2002:627833Other
Keywords:Cyclins Role: BSU (Biological study, unclassified), BIOL (Biological study) (D1 ajugasalicioside A inhibition of Jurkat T cell proliferation, up-regulation of mRNA levels of cyclin D1, and down-regulation of those of NF-kB subunit p65) Animal cell line (JURKAT ajugasalicioside A induction of cell-cell contact, inhibition of cell proliferation, and regulation of mRNA levels in) Transcription factors Role: BSU (Biological study, unclassified), BIOL (Biological study) (NF-kB (nuclear factor of k light chain gene enhancer in B-cells) ajugasalicioside A inhibition of Jurkat T cell proliferation, up-regulation of mRNA levels of cyclin D1, and down-regulation of those of NF-kB subunit p65) Cell proliferation (ajugasalicioside A inhibition of Jurkat T cell proliferation) mRNA Role: BSU (Biological study, unclassified), BIOL (Biological study) (ajugasalicioside A inhibition of Jurkat T cell proliferation, up-regulation of mRNA levels of cyclin D1, and down-regulation of those of NF-kB subunit p65) Mononuclear cell (ajugasalicioside C cytotoxicity to human cells) New natural products (ajugasaliciosides A-E (sterol glycosides) Antitumor agents (antileukemic sterol glycosides named ajugasaliciosides from Ajuga salicifolia as) Human (cytotoxicity of ajugasaliciosides to HeLa cells, Jurkat T cells, and human peripheral mononuclear blood cells) Cytotoxicity (of ajugasalicioside C to human peripheral mononuclear blood cells) Molecular structure (of ajugasaliciosides A-E (sterol glycosides) Glycosides Role: NPO (Natural product occurrence), PAC (Pharmacological activity), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) (steroidal cytotoxicity, isolation, and structure of antileukemic sterol glycosides from Ajuga salicifolia) antileukemic sterol glycoside Ajuga ajugasalicioside structure
Subjects:500 Science > 570 Life sciences
500 Science > 540 Chemistry & allied sciences
Status:Published
Refereed:Yes, this version has been refereed
Created at the University of Regensburg:No
Owner:Prof. Dr. Joerg Heilmann
Deposited On:18 Oct 2010 12:59
Last Modified:18 Oct 2010 12:59
Item ID:17201
Owner Only: item control page